Genesis procurement services secures key UK regulatory licence, strengthening global medicines supply

Genesis Procurement Services (GPS) has been granted the Wholesale Distribution Authorisation (Human) (WDA(H)) licence by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This achievement marks a significant step forward in our mission to deliver safe, compliant and high-quality pharmaceutical procurement and distribution services worldwide.

A rigorous benchmark for quality and compliance

Securing the WDA(H) licence requires strict adherence to Good Distribution Practices (GDP), the gold standard for ensuring the integrity of medicines throughout the supply chain. 

The MHRA’s approval is a testament to Genesis Analytics’s dedication to operational excellence, regulatory compliance, and, most importantly, patient safety.

With this licence, GPS is now formally authorised to wholesale human medicines in the UK and beyond, reinforcing Genesis Analytics’s ability to support healthcare providers, NGOs, and global health partners with reliable, end-to-end procurement and logistics solutions.

Whether sourcing essential medicines for low-resource settings or ensuring temperature-controlled distribution for critical therapies, this accreditation strengthens our capacity to operate at the highest standards.

Why this matters for global health

In an era where supply chain resilience and regulatory compliance are paramount, the WDA(H) licence elevates GPS’s role as a trusted partner in the pharmaceutical procurement space.

This milestone also unlocks new opportunities for collaboration. Many international donors, governments and humanitarian organisations require partners to hold MHRA or equivalent accreditation - meaning GPS is now even better positioned to support large-scale health initiatives with confidence.

What’s next?

With the WDA(H) licence in hand, GPS is poised to expand its impact, enhancing access to quality-assured medicines while maintaining the highest compliance standards.